Veterans Health Service Medical Center Reports Findings in Polycystic Ovary Syndrome (Trend changes and factor analysis of endometrial hyperplasia in patients with polycystic ovarian syndrome based on the Korean National Health Insurance …): Endocrine System Diseases and Conditions – Polycystic Ovary Syndrome

Information Technology Business Daily

2022 NOV 22 (NewsRx) -- By a News Reporter-Staff News Editor at Information Technology Business Daily -- New research on Endocrine System Diseases and Conditions - Polycystic Ovary Syndrome is the subject of a report. According to news reporting from Seoul, South Korea, by NewsRx journalists, research stated, “Polycystic ovary syndrome (PCOS) is a common endocrine disorder associated with an increased risk of other gynecological disorders, such as endometrial hyperplasia (EH). However, substantial factors in the comorbidity of EH and PCOS remain to be investigated.”

Financial support for this research came from Veterans Medical Research Institute,Veterans Health Service Medical Center.

The news correspondents obtained a quote from the research from Veterans Health Service Medical Center, “We analyzed trend changes in PCOS and factors related to the comorbidity of PCOS and EH using data from the Korea National Health Insurance (KNHI) claims database. The data for this population-based study of people diagnosed with PCOS or EH in Korea from 2009 to 2016 were collected from the KNHI claims database between 2007 and 2017. We conducted a trend analysis of the prevalence and incidence of PCOS and EH. In addition, we performed a logistic regression analysis to identify risk factors associated with EH incidence in people with PCOS using the matched case-control methodology. The average annual growth rate of the incidence of PCOS was 14.1% from 2009 to 2016, whereas the EH rate increased by only 3.4% annually. Comorbidities, type 2 diabetes, obesity, hypertension, hyperlipidemia, and infertility, increased the risk of EH in PCOS patients. Additionally, the cumulative duration of oral contraceptive & progestin treatment for PCOS correlated highly with the comorbidity of EH and PCOS. We confirmed the relationship between PCOS and EH using big data suitable for time series analyses of the diagnosis and treatment of diseases.”

According to the news reporters, the research concluded: “Endometrial evaluation should be done with more caution if oral contraceptives & progestins have been used for a long time.”

For more information on this research see: Trend changes and factor analysis of endometrial hyperplasia in patients with polycystic ovarian syndrome based on the Korean National Health Insurance Database. BMC Women’s Health, 2022;22(1):439. BMC Women’s Health can be contacted at: Bmc, Campus, 4 Crinan St, London N1 9XW, England. (BioMed Central - http://www.biomedcentral.com/; BMC Women’s Health - http://www.biomedcentral.com/bmcwomenshealth/)

Our news journalists report that additional information may be obtained by contacting Hakmo Lee, Veterans Medical Research Institute, Veterans Health Service Medical Center, Jinhwangdo-ro 61-gil 53, Gangdong-gu, Seoul, 05368, South Korea. Additional authors for this research include Bora Park, Suyeon Park, Eun Sil Lee, Jeong Jae Lee, Young Lee and Je Hyun Seo.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1186/s12905-022-02015-2. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.